Cameroon vs Madagascar: Prevalence rate of hypertension in adults aged 30-79
Cameroon
36.8
in 2019
Madagascar
36.9
in 2019
Cameroon rank
109th
Madagascar rank
108th
Prevalence rate of hypertension in adults aged 30-79 over time
- Cameroon
- Madagascar
How they compare
Madagascar currently reports 36.9 against 36.8 in Cameroon, a difference of 0.1.
Across all 30 years both countries report, Madagascar has been ahead every year.
Cameroon ranks 109th and Madagascar ranks 108th of 194 countries.
Madagascar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 33.46 | 37.89 | 4.43 | Madagascar |
| 2000s | 34.91 | 40.03 | 5.12 | Madagascar |
| 2010s | 36.49 | 38.74 | 2.25 | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in adults aged 30-79, Cameroon or Madagascar?
- Madagascar, at 36.9 against 36.8 in Cameroon as of 2019.
- What is the difference in prevalence rate of hypertension in adults aged 30-79 between Cameroon and Madagascar?
- 0.1, with Madagascar ahead.
- How many years of comparable data are there for Cameroon and Madagascar?
- 30 years are reported by both, from 1990 to 2019.
- How do Cameroon and Madagascar rank globally for prevalence rate of hypertension in adults aged 30-79?
- Cameroon ranks 109th and Madagascar ranks 108th of 194 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in adults aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of the population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.